# Topical Calcipotriol Versus Photodynamic Therapy in the Treatment of Oral Leukoplakia

> **NCT07658508** · PHASE2,PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Alexandria University** · enrollment: 30 (actual)

## Conditions studied

- Oral Leukoplakia

## Interventions

- **DRUG:** Calcipotriol 0.005% gel
- **DEVICE:** ALA mediated PDT

## Key facts

- **NCT ID:** NCT07658508
- **Lead sponsor:** Alexandria University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-07-16
- **Primary completion:** 2026-08-10
- **Final completion:** 2026-09-10
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2026-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07658508

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07658508, "Topical Calcipotriol Versus Photodynamic Therapy in the Treatment of Oral Leukoplakia". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07658508. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*